SZL P1-41
Based on 13 publication(s) in Google Scholar
SZL P1-41 is a specific Skp2 inhibitor, binds to the F-box domain of Skp2 to prevent Skp1 association and Skp2 SCF complex formation. SZL P1-41, like Skp2 deficiency, augments p27-mediated apoptosis/senescence, while it impairs Akt-driven glycolysis. Anti-tumor activities.
For research use only. We do not sell to patients.
- Purity: 99.07%
- CAS No.: 222716-34-9
- Formula: C24H24N2O3S
- Molecular Weight:420.52
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
Publications Citing Use of MedChemExpress (MCE) SZL P1-41
More- Leukemia. 2020 May;34(5):1241-1252. [Abstract]
- Pharmacol Res. 2022 Feb:176:106059. [Abstract]
- Cell Death Dis. 2022 Jul 13;13(7):606. [Abstract]
- Phytomedicine. 2024 Nov 9:135:156245. [Abstract]
- Cell Mol Life Sci. 2024 Jul 30;81(1):325. [Abstract]
- J Ethnopharmacol. 2024 Dec 23:340:119277. [Abstract]
- Commun Biol. 2023 Aug 2;6(1):805. [Abstract]
- Life Sci. 2021 Dec 16;289:120231. [Abstract]
- Eur J Pharmacol. 2026 Jan 12:1011:178422. [Abstract]
- Cancer Sci. 2021 Aug;112(8):3218-3232. [Abstract]
- Cell Biol Int. 2022 Jun;46(6):895-906. [Abstract]
- In Vitro Cell Dev Biol Anim. 2021 Aug;57(7):742-752. [Abstract]
- Research Square Print. October 12th, 2022.
-
WB
-
IHC
-
In Vivo Efficacy Study
-
Cell Imaging/Staining
-
Cell Proliferation/Viability Assay
Biological Activity
Skp2[1]
SZL P1-41 (5-20μM; 24 hours) induces endogenous p27 protein expression in PC3 cells and also induced expression of p21, another Skp2 substrate[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 222716-34-9
-
Appearance Solid
-
Molecular Weight 420.52
-
Formula C24H24N2O3S
-
Color Off-white to pink
-
SMILES
O=C1C(C2=NC3=CC=CC=C3S2)=COC4=C(CN5CCCCC5)C(O)=C(CC)C=C14
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 2 years -20°C 1 year
Publications (13)
-
Journal Impact Factor
-
Most Recent
-
Leukemia
2020 May;34(5):1241-1252. PMID: 31772299 -
Pharmacol Res
Brusatol has therapeutic efficacy in non-small cell lung cancer by targeting Skp1 to inhibit cancer growth and metastasis. [Abstract]2022 Feb:176:106059. PMID: 34998973 -
Cell Death Dis
Aurora-A/FOXO3A/SKP2 axis promotes tumor progression in clear cell renal cell carcinoma and dual-targeting Aurora-A/SKP2 shows synthetic lethality. [Abstract]2022 Jul 13;13(7):606. PMID: 35831273
SZL P1-41 purchased from MedChemExpress. Usage Cited in: Cell Death Dis. 2022 Jul 13;13(7):606. [Abstract]
Dual inhibition of Aur-A and SKP2 significantly increased protein levels of C-Cas-3, p21, p27, FOXO3A and decreased p-Aur-A, SKP2 and p-FOXO3A in ccRCC cells. 769-P cells were treated with MLN8237 (10 μM) or SZL P1-41 (20 μM), or combination of the two compounds, followed by the IB assay with indicated antibodies.
SZL P1-41 purchased from MedChemExpress. Usage Cited in: Cell Death Dis. 2022 Jul 13;13(7):606. [Abstract]
Immunohistochemical staining of xenograft tumor tissues. Tumor tissues from four groups of nude mice were fixed, sectioned, and stained with indicated antibodies treated with SZL P1-41 (80 mg/kg/day of every day for 4 weeks).
SZL P1-41 purchased from MedChemExpress. Usage Cited in: Cell Death Dis. 2022 Jul 13;13(7):606. [Abstract]
The tumors were harvested and tumor growth was monitored treated with SZL P1-41 (80 mg/kg/day of every day for 4 weeks).
SZL P1-41 purchased from MedChemExpress. Usage Cited in: Cell Death Dis. 2022 Jul 13;13(7):606. [Abstract]
Combination of MLN8237 and SZL P1-41 inhibited clonogenic ability in ccRCC cells. 769-P cells were treated with MLN8237 (10 μM) or SZL P1-41 (20 μM) alone or combination of the two compounds, followed by the colony formation assay.
SZL P1-41 purchased from MedChemExpress. Usage Cited in: Cell Death Dis. 2022 Jul 13;13(7):606. [Abstract]
IC50 values of SZL P1-41 (0, 0.39, 0.78, 1.56, 3.125, 6.25, 12.5, 25, 50, and 100 μM, 48 h) in five ccRCC cell lines and HK-2 cell line by the CCK-8 assay.
-
Phytomedicine
Ginkgo biloba extract alleviates deltamethrin-induced testicular injury by upregulating SKP2 and inhibiting Beclin1-independent autophagy. [Abstract]2024 Nov 9:135:156245. PMID: 39550920 -
Cell Mol Life Sci
Suppression of Skp2 contributes to sepsis-induced acute lung injury by enhancing ferroptosis through the ubiquitination of SLC3A2. [Abstract]2024 Jul 30;81(1):325. PMID: 39079969 -
J Ethnopharmacol
Centipeda minima extracts and the active sesquiterpene lactones have therapeutic efficacy in non-small cell lung cancer by suppressing Skp2/p27 signaling pathway. [Abstract]2024 Dec 23:340:119277. PMID: 39722328 -
Commun Biol
Skp2-mediated MLKL degradation confers cisplatin-resistant in non-small cell lung cancer cells. [Abstract]2023 Aug 2;6(1):805. PMID: 37532777 -
Life Sci
Skp2 promotes APL progression through the stabilization of oncoprotein PML-RARα and the inhibition of JunB expression. [Abstract]2021 Dec 16;289:120231. PMID: 34921867 -
Eur J Pharmacol
Targeting Skp2 by camptothecin induces p27 accumulation and confers drug resistance in non-small cell lung cancer. [Abstract]2026 Jan 12:1011:178422. PMID: 41344534 -
Cancer Sci
Phytochemical library screening reveals betulinic acid as a novel Skp2-SCF E3 ligase inhibitor in non-small cell lung cancer. [Abstract]2021 Aug;112(8):3218-3232. PMID: 34080260 -
Cell Biol Int
Inhibition of Skp2 enhances doxorubicin-induced cell death in B cell precursor acute lymphoblastic leukemia. [Abstract]2022 Jun;46(6):895-906. PMID: 35143089 -
In Vitro Cell Dev Biol Anim
Cyclin-dependent kinase inhibitor 1B acts as a novel molecule to mediate testosterone synthesis and secretion in mouse Leydig cells by luteinizing hormone (LH) signaling pathway. [Abstract]2021 Aug;57(7):742-752. PMID: 34355300 -
Solvent & Solubility
DMSO : 2.5 mg/mL (5.95 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
For the following dissolution methods, please prepare the working solution directly:
It is recommended to prepare fresh solutions and use them promptly within a short period of time.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: Corn Oil
Solubility: 5 mg/mL (11.89 mM); Suspended solution; Need ultrasonic
Purity & Documentation
-
Data Sheet (276 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
[1]. Chan CH et al. Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression. Cell. 2013 Aug 1;154(3):556-68. [Content Brief]
[2]. Chan CH, et al. Skp2: a dream target in the coming age of cancer therapy. Cell Cycle. 2014;13(5):679-80. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.3780 mL | 11.8900 mL | 23.7801 mL | 59.4502 mL |
| 5 mM | 0.4756 mL | 2.3780 mL | 4.7560 mL | 11.8900 mL |